# Catalent

全球 GMP 产能（Lonza 瑞士 Visp/美国、Catalent、Thermo Fisher Patheon），使申办方无需自建工厂即可在区域内生产。

Source: https://cn.bioecon.ru/companies/catalent/
Updated: 2026-06-24

- 国家: United States

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 累计融资$11.5亿 | https://intuitionlabs.ai/articles/top-cdmo-companies-2026-ranked |
| 产能 | 一次性生物反应器最高2,000升；Harmans/BWI设有16间GMP车间；麦迪逊基地拥有多台2,000升反应器 | https://intuitionlabs.ai/articles/top-cdmo-companies-2026-ranked, https://www.catalent.com/locations/harmans-bwi-united-states, https://www.catalent.com/locations/madison-united-states, https://www.catalent.com/pharma/biologics/manufacturing/cgmp-drug-substance-manufacturing |
| 认证 | 获FDA CGMP、EMA、PMDA、ANVISA、俄罗斯卫生部、ISO 14001、ISO 45001、Ecovadis GOLD及HPRA GMP认证 | https://www.catalent.com/locations/harmans-bwi-united-states, https://www.catalent.com/locations/madison-united-states |
| 监管批准 | 支持获得多项监管批准，包括FDA CBER、EMA、PMDA、ANVISA及俄罗斯卫生部 | https://www.catalent.com/locations/harmans-bwi-united-states, https://www.catalent.com/locations/madison-united-states |
| 生产基地 | 全球40余处基地，主要枢纽包括威斯康星州麦迪逊及马里兰州Harmans/BWI | https://www.catalent.com/locations |
| 营收 | $43.8亿（2024财年） | https://intuitionlabs.ai/articles/top-cdmo-companies-2026-ranked, https://www.sec.gov/Archives/edgar/data/1596783/000159678324000033/R46.htm |

独立来源: intuitionlabs.ai, sec.gov

## 技术

- [生物生产 CDMO/CMO (生物制剂/ATMP/mRNA)](https://cn.bioecon.ru/technology/bioproduction-cdmo-cmo/)
- [面向市场准入的本地化生产](https://cn.bioecon.ru/technology/local-manufacturing-for-market-access/)